Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 506 entries
View as:

Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)

Phase: N/A Priority: Normal
NCT ID: NCT01523821 Org: User:
Start: 10/11/13 End: 01/15/17 Due: 01/15/18

Diet and Systemic Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT01424306 Org: User:
Start: 10/31/11 End: 04/30/14 Due: 04/30/15

Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT01930981 Org: User:
Start: 10/31/12 End: 06/30/16 Due: 06/30/17

Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01076270 Org: User:
Start: 06/30/10 End: 02/28/11 Due: 02/28/12

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01640301 Org: User:
Start: 12/06/12 End: 03/20/20 Due: 03/20/21

Carotene and Retinol Efficacy Trial

Phase: N/A Priority: Normal
NCT ID: NCT00712647 Org: User:
Start: 05/31/85 End: 06/30/05 Due: 06/30/06

Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00871481 Org: User:
Start: 02/28/09 End: 10/31/13 Due: 10/31/14

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

Phase: N/A Priority: Normal
NCT ID: NCT00209313 Org: User:
Start: 03/31/05 End: 04/30/07 Due: 04/30/08

Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission

Phase: N/A Priority: Normal
NCT ID: NCT00045435 Org: User:
Start: 04/30/02 End: 01/31/09 Due: 01/31/10

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03397186 Org: User:
Start: 06/19/18 End: 05/01/21 Due: 05/01/22

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003874 Org: User:
Start: 02/28/99 End: 09/30/01 Due: 09/30/02

Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT02408016 Org: User:
Start: 05/22/15 End: 06/30/20 Due: 06/30/21

Glucosamine and Chondroitin Effects

Phase: N/A Priority: Normal
NCT ID: NCT01682694 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

Glasdegib for Chronic Graft-Versus-Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT04111497 Org: User:
Start: 12/03/19 End: 08/23/23 Due: 08/23/24

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005854 Org: User:
Start: 12/31/99 End: 10/31/00 Due: 10/31/01

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00553098 Org: User:
Start: 06/30/06 End: - Due: -

Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT01097057 Org: User:
Start: 11/09/10 End: 12/26/17 Due: 12/26/18

Vitamin D and Adipose Tissue Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT01477034 Org: User:
Start: 11/30/11 End: 06/30/13 Due: 06/30/14

Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00918723 Org: User:
Start: 06/30/09 End: 10/31/16 Due: 10/31/17

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01251575 Org: User:
Start: 12/01/10 End: 02/11/19 Due: 02/11/20

Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda

Phase: N/A Priority: Normal
NCT ID: NCT02316444 Org: User:
Start: 11/30/15 End: 04/28/17 Due: 04/28/18

Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04062955 Org: User:
Start: 10/28/19 End: 11/19/20 Due: 11/19/21

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

Phase: N/A Priority: Normal
NCT ID: NCT00914940 Org: User:
Start: 12/17/09 End: 05/26/20 Due: 05/26/21

Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002553 Org: User:
Start: 08/31/90 End: 06/30/03 Due: 06/30/04

Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01807182 Org: User:
Start: 08/20/13 End: 08/26/21 Due: 08/26/22